Download PDF
Semin Respir Crit Care Med 2012; 33(02): 199-204
DOI: 10.1055/s-0032-1311800
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Chronic Pulmonary Embolism and Pulmonary Hypertension

Frederikus A. Klok
1   Department of Thrombosis and Haemostasis, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
2   Department of General Internal Medicine, Bronovo Hospital, Den Haag, The Netherlands.
,
Inge C.M. Mos
1   Department of Thrombosis and Haemostasis, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
3   Department of Internal Medicine, MC Haaglanden, Den Haag, The Netherlands.
,
Klaus W. van Kralingen
4   Department of Pulmonary Medicine, Leiden University Medical Center, Leiden, The Netherlands.
,
Jelmer E. Vahl
2   Department of General Internal Medicine, Bronovo Hospital, Den Haag, The Netherlands.
5   Department of Pulmonary Medicine, HAGA Ziekenhuis, Den Haag, The Netherlands.
,
Menno V. Huisman
1   Department of Thrombosis and Haemostasis, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
› Author Affiliations
Further Information

Publication History

Publication Date:
30 May 2012 (online)

    Permissions and Reprints

Abstract

Incomplete resolution of acute pulmonary embolism (PE) is frequently observed after acute PE and may rarely result in chronic thromboembolic pulmonary hypertension (CTEPH). The underlying pathophysiological mechanism is largely unknown. Evidence underlines the concept of a dual pulmonary vascular compartment model consisting of increased pulmonary vascular resistance by both large vessel obstruction and distal small vessel obliteration, the latter initiated by pathological vascular remodeling. Up to 40% of patients with established CTEPH have no prior history of symptomatic venous thromboembolism. CTEPH is associated with a poor prognosis if left untreated. Therefore, the diagnostic approach of CTEPH aims at assessing the location and extent of the embolic obstruction, establishing the operability and prognosis of the patients and ruling out other variations of pulmonary hypertension with distinct indicated treatment. Heart catheterization for invasive pressure measurements and pulmonary catheter angiography is obligatory for the final diagnosis. Pulmonary thromboendarterectomy is the treatment of choice. In certain patients with persistent or recurrent pulmonary hypertension after surgery or with inoperable disease, pharmacotherapy might be beneficial.

Keywords

pulmonary embolism - chronic thromboembolic pulmonary hypertension - diagnosis - therapy - prognosis
 

  • References

  • 1 Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010; 363 (3) 266-274
    CrossrefPubMedGoogle Scholar
  • 2 Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121 (3) 877-905
    CrossrefPubMedGoogle Scholar
  • 3 Klok FA, Zondag W, van Kralingen KW , et al. Patient outcomes after acute pulmonary embolism: a pooled survival analysis of different adverse events. Am J Respir Crit Care Med 2010; 181 (5) 501-506
    CrossrefPubMedGoogle Scholar
  • 4 Klok FA, Mos ICM, Broek L , et al. Risk of arterial cardiovascular events in patients after pulmonary embolism. Blood 2009; 114 (8) 1484-1488
    CrossrefPubMedGoogle Scholar
  • 5 Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113 (16) 2011-2020
    CrossrefPubMedGoogle Scholar
  • 6 Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345 (20) 1465-1472
    CrossrefPubMedGoogle Scholar
  • 7 Hoeper MM, Barberà JA, Channick RN , et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1, Suppl) S85-S96
    CrossrefPubMedGoogle Scholar
  • 8 Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81 (2) 151-158
    CrossrefPubMedGoogle Scholar
  • 9 Nijkeuter M, Hovens MM, Davidson BL, Huisman MV. Resolution of thromboemboli in patients with acute pulmonary embolism: a systematic review. Chest 2006; 129 (1) 192-197
    CrossrefPubMedGoogle Scholar
  • 10 Kaczyńska A, Kostrubiec M, Pacho R, Kunikowska J, Pruszczyk P. Elevated D-dimer concentration identifies patients with incomplete recanalization of pulmonary artery thromboemboli despite 6 months anticoagulation after the first episode of acute pulmonary embolism. Thromb Res 2008; 122 (1) 21-25
    CrossrefPubMedGoogle Scholar
  • 11 Stein PD, Yaekoub AY, Matta F , et al. Resolution of pulmonary embolism on CT pulmonary angiography. AJR Am J Roentgenol 2010; 194 (5) 1263-1268
    CrossrefPubMedGoogle Scholar
  • 12 Golpe R, Pérez-de-Llano LA, Castro-Añón O , et al. Right ventricle dysfunction and pulmonary hypertension in hemodynamically stable pulmonary embolism. Respir Med 2010; 104 (9) 1370-1376
    CrossrefPubMedGoogle Scholar
  • 13 Miniati M, Monti S, Bottai M , et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) 2006; 85 (5) 253-262
    CrossrefPubMedGoogle Scholar
  • 14 Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism. One-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation 1999; 99 (10) 1325-1330
    CrossrefPubMedGoogle Scholar
  • 15 Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation 1992; 86 (4) 1241-1248
    CrossrefPubMedGoogle Scholar
  • 16 Morris TA, Marsh JJ, Chiles PG , et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood 2009; 114 (9) 1929-1936
    CrossrefPubMedGoogle Scholar
  • 17 Morris TA, Marsh JJ, Chiles PG, Auger WR, Fedullo PF, Woods Jr VL. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med 2006; 173 (11) 1270-1275
    CrossrefPubMedGoogle Scholar
  • 18 Wolf M, Boyer-Neumann C, Parent F , et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000; 15 (2) 395-399
    CrossrefPubMedGoogle Scholar
  • 19 Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 2000; 15 (3) 440-448
    CrossrefPubMedGoogle Scholar
  • 20 Lang I. Advances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension. Br J Haematol 2010; 149 (4) 478-483
    CrossrefPubMedGoogle Scholar
  • 21 Moser KM, Braunwald NS. Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension. Chest 1973; 64 (1) 29-35
    CrossrefPubMedGoogle Scholar
  • 22 Tuder RM, Abman SH, Braun T , et al. Development and pathology of pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1, Suppl) S3-S9
    CrossrefPubMedGoogle Scholar
  • 23 Bogatcheva NV, Garcia JG, Verin AD. Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc) 2002; 67 (1) 75-84
    PubMedGoogle Scholar
  • 24 Pengo V, Lensing AW, Prins MH , et al; Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350 (22) 2257-2264
    CrossrefPubMedGoogle Scholar
  • 25 Becattini C, Agnelli G, Pesavento R , et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 2006; 130 (1) 172-175
    CrossrefPubMedGoogle Scholar
  • 26 Dentali F, Donadini M, Gianni M , et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res 2009; 124 (3) 256-258
    CrossrefPubMedGoogle Scholar
  • 27 Miniati M, Monti S, Bottai M , et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) 2006; 85 (5) 253-262
    CrossrefPubMedGoogle Scholar
  • 28 Klok FA, van Kralingen KW, van Dijk APJ, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica 2010; 95 (6) 970-975
    CrossrefPubMedGoogle Scholar
  • 29 Tuder RM, Abman SH, Braun T , et al. Development and pathology of pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1, Suppl) S3-S9
    CrossrefPubMedGoogle Scholar
  • 30 Bonderman D, Wilkens H, Wakounig S , et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009; 33 (2) 325-331
    CrossrefPubMedGoogle Scholar
  • 31 Klok FA, Tijmensen JE, Haeck ML, van Kralingen KW, Huisman MV. Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: results of a questionnaire. Eur J Intern Med 2008; 19 (8) 625-629
    CrossrefPubMedGoogle Scholar
  • 32 Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism. Respir Med 2010; 104 (11) 1744-1749
    CrossrefPubMedGoogle Scholar
  • 33 McLaughlin VV, Archer SL, Badesch DB , et al; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53 (17) 1573-1619
    CrossrefPubMedGoogle Scholar
  • 34 Huisman MV, Klok FA. Diagnostic management of clinically suspected acute pulmonary embolism. J Thromb Haemost 2009; 7 (Suppl. 01) 312-317
    PubMedGoogle Scholar
  • 35 Tunariu N, Gibbs SJ, Win Z , et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007; 48 (5) 680-684
    CrossrefPubMedGoogle Scholar
  • 36 Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992; 182 (2) 393-398
    PubMedGoogle Scholar
  • 37 Klok FA, Surie S, Kempf T , et al. A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Thromb Res 2011; 128 (1) 21-26 DOI: 10.1016/j.thromres.2011.03.004.
    CrossrefPubMedGoogle Scholar
  • 38 Archibald CJ, Auger WR, Fedullo PF , et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999; 160 (2) 523-528
    CrossrefPubMedGoogle Scholar
  • 39 Jamieson SW, Kapelanski DP, Sakakibara N , et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003; 76 (5) 1457-1462 , discussion 1462–1464
    CrossrefPubMedGoogle Scholar
  • 40 Corsico AG, D'Armini AM, Cerveri I , et al. Long-term outcome after pulmonary endarterectomy. Am J Respir Crit Care Med 2008; 178 (4) 419-424
    CrossrefPubMedGoogle Scholar
  • 41 Keogh AM, Mayer E, Benza RL , et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1, Suppl) S67-S77
    CrossrefPubMedGoogle Scholar
  • 42 Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2007; 28 (1) 255-269 , x
    CrossrefPubMedGoogle Scholar
  • 43 Condliffe R, Kiely DG, Gibbs JS , et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008; 177 (10) 1122-1127
    CrossrefPubMedGoogle Scholar
  • 44 Bonderman D, Skoro-Sajer N, Jakowitsch J , et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007; 115 (16) 2153-2158
    CrossrefPubMedGoogle Scholar
  • 45 Freed DH, Thomson BM, Berman M , et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 2011; 141 (2) 383-387
    CrossrefPubMedGoogle Scholar
  • 46 Ghofrani HA, Schermuly RT, Rose F , et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003; 167 (8) 1139-1141
    CrossrefPubMedGoogle Scholar
  • 47 Reichenberger F, Voswinckel R, Enke B , et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007; 30 (5) 922-927
    CrossrefPubMedGoogle Scholar
  • 48 Jaïs X, D'Armini AM, Jansa P , et al; Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension Study Group. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008; 52 (25) 2127-2134
    CrossrefPubMedGoogle Scholar
  • 49 Becattini C, Manina G, Busti C, Gennarini S, Agnelli G. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. Thromb Res 2010; 126 (1) e51-e56
    CrossrefPubMedGoogle Scholar
  • 50 Bresser P, Fedullo PF, Auger WR , et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23 (4) 595-600
    CrossrefPubMedGoogle Scholar
  • 51 Skoro-Sajer N, Bonderman D, Wiesbauer F , et al. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost 2007; 5 (3) 483-489
    CrossrefPubMedGoogle Scholar